Navigation Links
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
Date:6/25/2009

ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting

RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc. (NYSE: KG) today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations that are in development, at the 71st Annual Meeting of the College on Problems of Drug Dependence. King is also developing other pain medicines employing unique technology platforms designed to address risks associated with currently marketed opioids.

"We anticipate that ACUROX(R) and EMBEDA(TM), upon approval, will offer new therapeutic tools for physicians treating people living with pain," said Eric Carter, Chief Science Officer of King Pharmaceuticals. "Our expectation is that these novel technologies could become instrumental in a physician's arsenal of safe and effective pain medicines that can help with an overall risk management plan."

Highlights of King's presentations and King supported presentations are as follows:

ACUROX(R) (oxycodone HCl/niacin) Tablets for the Treatment of Acute, Moderate to Severe Pain Following Bunionectomy Surgery in Adult Patients

ACUROX(R) Tablets are a unique composition of short-acting oxycodone HCl, niacin and functional inactive ingredients intended to relieve moderate to severe pain. A Phase III study evaluated the analgesic efficacy and safety of ACUROX(R) in adults with moderate to severe pain following bunionectomy surgery. The 405 participants received either two ACUROX(R) Tablets 7.5/30 mg, two ACUROX(R) Tablets 5/30 mg or two placebo tablets every six hours for 48 hours after surgery. Both doses of ACUROX(R) Tablets demonstrated significant reduction in pain compared to placebo. The adv
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...IEGO, Nov. 6 California American W...s "No Drugs Down the Drain" week for its San Diego...n sponsored by public and private agencies alike t...l pollution in our source water supplies. ,, Ca...rs are encouraged to drop off expired or unwanted ...
(Date:11/5/2009)...TOWN, N.J., Nov. 5 Osteo...ing field of biologic products for regenerative he...ird quarter ended September 30, 2009. ,, "Durin...release of our three new biologic products MagniF...y and Plexur M® Innovative Grafting," said Sa...
(Date:11/5/2009)... RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCall/ -..., a specialty pharmaceutical company focused on th... products that address important therapeutic needs...will host a webcast and teleconference with manage...ts on Thursday, November 12, 2009, at 5:00 p.m. Ea...
Breaking Medicine Technology:California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2DNA2 0 Awarded US Patents for Breakthrough Gene Optimization Technology Company 26apos 3Bs Unique Algorithm Enables Expression Yields up to 50 Time 12565 1DNA2 0 Awarded US Patents for Breakthrough Gene Optimization Technology Company 26apos 3Bs Unique Algorithm Enables Expression Yields up to 50 Time 12565 2DNA2 0 Awarded US Patents for Breakthrough Gene Optimization Technology Company 26apos 3Bs Unique Algorithm Enables Expression Yields up to 50 Time 12565 3PhRMA Launches Campaign to Raise Awareness of Success of Medicare Prescription Drug Benefit 48446 1PhRMA Launches Campaign to Raise Awareness of Success of Medicare Prescription Drug Benefit 48446 2Astellas Names Head of Global R 26D Operations 48444 1Astellas Names Head of Global R 26D Operations 48444 2
..., LAS VEGAS, Feb. 25 The following was issued tod...: , , Hip Replacement , ( http://www3.aaos.o...ent=P064 ) , , , Hip Resurfacing Disap... , , , , Using a common mechanism to score...und that the majority of patients who underwent a ...
..., Primate trials validate efficacy of the process ...s, Inc. announced today that it has successfully c... efficacy of the proprietary bone growth regenerat...y. 100% fusion was obtained in a 3 month period. ...rrently preparing Pre-IDE studies. , , Bone Biolo...
Other Medicine Technology:American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 2American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 3American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 4American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 5American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 6American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 7American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 8American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 9American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics' 10Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix 2
(Date:11/7/2009)...ack to stem a growing problem across the U.S. , ...y half of students at four-year colleges do it reg...rinking -- downing five or more alcoholic drinks a...g alcohol as a drug," said Jenny Hwang, associate ...nter at Stony Brook University on Long Island, N.Y...
(Date:11/6/2009)... TSX: COM , VANCOUVER, Nov. 6 /PRNewswire-FirstC...: COM) today announced that it will report financi...0, 2009 on the morning of Monday, November 9, 2009...cast at 9:00am Eastern (6:00am Pacific) on that da...nce call, please dial 416-695-7806 or 888-789-9572...
(Date:11/6/2009).... 6 Centene Corporation (NYSE: CNC ) today annou...re conferences over the next few weeks. ,, Next we...onference, to be held November 11-13, 2009, at the...ne will present Wednesday, November 11th at 4:30 p...parties may access Centene,s presentation at: ht...
(Date:11/6/2009)...Nov. 6 Plan International, a leading children,s d...es around the world, has been asked to deliver eig...ng at the upcoming American Public Health Associat...iladelphia, Pennsylvania on November 7-11, 2009. ...organizations together to address current and emer...
(Date:11/6/2009)...cy, clinic and government programs, expert says , ...ecession has made it more difficult than ever befo...ations, but several options are available, accordi...olis. , First, talk to your pharmacist, advised Ca...professor of pharmacy practice at Butler,s College...
Breaking Medicine News(10 mins):Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Centene Corporation to Present at Upcoming Healthcare Conferences 2Health News:Plan's Expertise Highlighted at Premier Health Forum 2Health News: Pay Less for Prescription Drugs 2
...irst heart transplant patient whose donor heart wa... The pioneering operation was performed on the ...uth Wales on 20 February after her body rejected h...attached to it. The operation was performed by...
...gst Italian scientists to show that high cholester... though more studies to prove the same is welcome....on of male hormones that cause prostate cancer, wh...sk of getting afflicted with cancer The resea...
...winner of the prestigious Dada Saheb Phalke Award,...is afternoon. //The superstar had come in the lime...smuggler Veerappan for more than 100 days, about s...ysician Dr Ramana Rao said. Dr Bhujanga Shetty of ...
...ods it ahs been found that survival rates followin... three-fold when emergency medical// personnel use... Arizona Sarver Heart Center. Cardiocerebral Res...ael J. Kellum, MD, leading author of the study rep...
...in 2000 and was later recommendation for all child... in the rates of pneumonia among young infants. /...ease among children younger than 2 years of age wa...tion rate. But in the present study that was condu...
...ases are an urban lifestyle phenomenon, a three-ye... revealed that heart-related problems// are the la...ive leading institutes led by the Byrraju Foundati...se Control (CCDC), the CARE Foundation in India, t...
Other Medicine News:Health News:Donor Heart Gives Way for Patient’s Own Hear 2Health News:Paramedics save more lives following unconventional rules 2Health News:Mortality Rates Due To Heart Diseases Is High In Rural Areas Too 2
...ings where a more secure band is desired for adult...ve wristband is appropriate. The design allows for... be placed on the wrist and the second to be held ...This is particularly useful in a hospital situatio...
IDENTI-PRINT II
IDENTI-MATCH II
Digital High Mag
Medicine Products: